Codiak BioSciences
@codiakbio
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines. $CDAK
ID: 731278353181855744
http://www.codiakbio.com 14-05-2016 00:22:00
156 Tweet
318 Followers
11 Following
FierceBiotech
@fiercebiotech
The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Michael Gilman
@michael_gilman
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Meg Tirrell
@megtirrell
Medical correspondent @CNN
Luke Timmerman
@ldtimmerman
Biotech journalist. Founder @TimmermanReport.
Daphne Zohar
@daphnezohar
Founder & CEO of @SeaportTX. Co-founder Karuna Tx (now at BMS). Founding CEO & now Senior Advisor @PureTechH. Co founder/host @BiotechCH. Board EC @IamBiotech
John Carroll
@johncendpts
47 yrs before the mast. Invented FierceBiotech, founded Endpoints News w/ 230,000 subs. Devoting time to the big showdown with Merkel cell carcinoma . We'll see
Laura Strong
@scientre
Sci(entist)Entre(preneur) Data science + analytics; Former cancer drugs and early detection #pharma #healthtech #healthcare #innovation Teach #biotech UWMadison
BioCentury
@biocentury
The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: bit.ly/4b1HDDu
Bruce Booth
@lifescivc
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Exosome RNA
@exosomerna
Exosomes are cell-derived vesicles that are present in many and perhaps all biological fluids, including blood, urine, and cultured medium of cell cultures....
Molecular Cancer Therapeutics
@mct_aacr
The go-to journal for transitioning experimental therapies developed at the bench into clinical investigation, from preclinical study to phase I trials.